VEGFA and nonpapillary renal cell carcinoma: Approximately 50%-70% of cases of renal cell carcinoma (ccRCC) involve Von Hippel Lindau (VHL) as a biomarker, along with markers like anhydrase and vascular endothelial growth factor (VEGF).